The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012;43:3375 3377. 199. Dentali F, Poli D, Scoditti U, Di Minno MN, De Stefano V, Siragusa S, Kostal M, Palareti G, Sartori MT, Grandone E, Vedovati MC, Ageno W; for the CEVETIS (CErebral VEin Thrombosis International Study) Investigators. Long-term outcomes of patients with cerebral vein throm- bosis: a multicenter study [published correction appears in J Thromb Haemost. 2013;11:399]. J Thromb Haemost. 2012;10:1297 1302. 200. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY; on behalf of the American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cere- bral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158 1192. 201. deVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sinclair DB,Yager J; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in chil- dren. N Engl J Med. 2001;345:417 423. 202. Ferro JM, Canh o P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36:1927 1932. 203. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793 1797. 204. Bousser MG, Crassard I. Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res. 2012;130(suppl 1):S19 S22. 205. Ahrens I, Peter K, Lip GY, Bode C. Development and clinical appli- cations of novel oral anticoagulants, part I: clinically approved drugs. Discov Med. 2012;13:433 443. 206. 